Fundamentals to Watch About EyePoint Pharmaceuticals (EYPT)

By Kim Brooks • Wednesday, November 01 15:30 • Permanent Link

Shares of Small-cap industrials company EyePoint Pharmaceuticals moved 19.9 this afternoon, and are now trading at $7.21 per share. On the other hand, the average analyst target price for the stock is $31.75.

EyePoint Pharmaceuticals, Inc. focuses on developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders.

EyePoint Pharmaceuticals Investors Should Consider This:

EyePoint Pharmaceuticals has moved 41.0% over the last year.
Its Price to Book (P/B) ratio is 4.32

Focus on EyePoint Pharmaceuticals's Operating Margins

Date Reported	Total Revenue ($ k)	Net Profit ($ k)	Net Margins (%)
2023	nan	-105,956
2022	nan	-102,254
2021	nan	-58,417
2020	nan	-45,394
2019	nan	nan	nan
2018	4,571	-86,125	nan

None None

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.